Qube Research & Technologies LTD Provention Bio, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.7 - $24.21 $354,718 - $1.28 Million	52,943 Added 52.23%	154,314 $3.72 Million
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $458,196 - $1.07 Million	101,371 New	101,371 $1.07 Million
Q2 2021 Aug 13, 2021	SELL	$6.71 - $11.04 $169,561 - $278,980	-25,270 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$10.12 - $19.45 $255,732 - $491,501	25,270 New	25,270 $265,000
Q2 2020 Aug 14, 2020	SELL	$7.81 - $17.0 $281,378 - $612,476	-36,028 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.42 - $17.75 $614,432 - $2.01 Million	-113,364 Reduced 75.88%	36,028 $331,000
Q4 2019 Feb 13, 2020	BUY	$5.84 - $14.9 $872,449 - $2.23 Million	149,392 New	149,392 $2.23 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.